Materials | Working mechanisms | Applications | References | |||
---|---|---|---|---|---|---|
Enzymatic biomaterials | Natural enzymes-based biomaterials | CAT-based materials | Decomposition of hydrogen peroxide into molecular oxygen and water | Anti-inflammation wound dressing | ||
SOD-based materials | Catalysis of superoxide into oxygen and hydrogen peroxide | Chronic wound healing; trauma treatment | ||||
Modulating natural enzymes biomaterials | Nrf2-activating materials | Activation of Nrf2 | Skin inflammation; traumatic brain injury; osteoporotic bone defects | |||
Collagen-based sponge | Activation of SOD and GPx | Wound healing | ||||
Bioactive glasses containing Sr | Activation of SOD, CAT, and GPx | Repair and regeneration of wound and bone | ||||
Nanozymes | Ce-contained nanozymes | SOD- and CAT-mimetic nanozyme activities | Periodontitis; Acute lung injury; Spinal cord injury; Refractory wound healing; Diabetic wound healing Age-related macular degeneration; Premature skin aging and cancer; Sepsis | |||
Mn-contained nanozymes | SOD- and CAT-mimetic nanozyme activities | Ear inflammation; Gingivitis; Periodontitis | ||||
Cu-contained nanozymes | GPx-, SOD-, and CAT-mimetic nanozyme activities | Acute kidney injury; Acute liver injury; Wound healing | ||||
Pt-contained nanozymes | GPx-, SOD-, and CAT-mimetic nanozyme activities | Osteoarthritis; UVB-induced inflammation | ||||
Prussian blue-contained nanozymes | ||||||
Carbon dots nanozymes | ||||||
Prussian blue-contained nanozymes | POD-, SOD-, and CAT-mimetic nanozyme activities | Osteoarthritis; Hepatic ischemia‒reperfusion injury; Wound healing | ||||
Carbon dots nanozyme | SOD-mimetic nanozyme activities | Ulcerative colitis | ||||
Artificial selenoenzymes | Diphenyl diselenide | GPx-mimetic activity | Chronic T. gondii infection; Ischemia/reperfusion; Amyotrophic lateral sclerosis | |||
Ebselen | GPx-mimetic activity | Influenza; Glioma; H. pylori-induced cell damage | ||||
Direct ROS scavenging biomaterials | Polyphenols | Curcumin | Free radical scavenging by H-atom transfer or electron transfer | Neuroprotection; Wound healing; Ischemia‒reperfusion injury; Acute kidney injury; Acute liver injury; Ankle inflammation | ||
Polydopamine | Free radical scavenging; Chelation of metal ions; SOD-mimetic activity | Periodontitis; Acute kidney injury; inflammatory bowel disease | ||||
Tannic acid | Free radical scavenging; Chelation of metal ions | Wound healing; Inflammatory bowel disease; Liver injury; Ischemic stroke; Cognitive impairment; Skin protection; Bone renovation and regeneration; Osteoarthritis | ||||
H2-based materials | – | Chemical reactions with ROS; Activation of Nrf2; Activation of SOD and GSH; Downregulation of NOX-2 | Airway disease; Periodontitis; Psoriasis; Foot inflammation | |||
Sulfur-based oxidation-responsive biomaterials | Thioether/sulfoxide-contained biomaterials | Redox reactions with ROS | Neuroprotection; Diabetes; Interstitial cystitis; Rheumatoid arthritis | |||
Thioacetals/thioketals-contained biomaterials | Redox reactions with ROS | Ankle inflammation; Ischemic wound healing; Repair of bone defects | ||||
Hydrogen sulfide | Redox reactions with ROS | Cardiovascular inflammatory diseases; Neurodegenerative diseases | ||||
Bilirubin-derived biomaterials | – | Free radicals scavenging by H-atom; Bilirubin–biliverdin cycle; Intranuclear regulation concerning Nrf2, HO-1, and antioxidants | Asthma; acute pancreatitis; osteoarthritis; Ulcerative colitis; Cardiac ischemia–Reperfusion injury; Hepatic ischemia–Reperfusion injury; Rosacea; Psoriasis; Pulmonary fibrosis | |||
ROS generation-inhibiting biomaterials | NOX-inhibiting biomaterials | – | Downregulation the production of ROS by inhibiting NOX | Arthritis; Ulcerative colitis; Asthma; Ischemia/reperfusion-Induced brain injury | ||
XO-inhibiting biomaterials | – | Downregulation the production of ROS by inhibiting XO | Anti-inflammation; Hyperuricemia | |||
LOX-inhibiting biomaterials | – | Downregulation the production of ROS by inhibiting LOX | Peritonitis; Asthma | |||
ETC-regulating biomaterials | – | Downregulation the production of ROS by regulating the activities of ETC | Alzheimer’s disease |